CROI Conference 2018
08 Mar 2018
Sunday 4 March marked the beginning of the CROI Conference 2018, where the MRC Clinical Trials Unit at UCL presented results from several HIV trials, including REALITY, CHER, and START.
CROI is a global model of collaborative science and the premier international venue for bridging basic and clinical investigation to clinical practice in the field of HIV and related viruses.
CROI 2018 took place from Sunday 4 March to Wednesday 7 March, in Boston, Massachusetts, at the Hynes Convention Center.
Details of the MRC CTU at UCL presentations that took place at CROI 2018 are shown below.
|
Day |
Time |
Type |
Title |
Authors |
Location |
|
05 March 2018 |
10:15 - 10:30 |
Oral Abstract session |
23 - Impact of Raltegravir Intensification of First-Line ART on Iris in The REALITY Trial |
Gibb, D |
Auditorium Front Section |
|
05 March 2018 |
14:30 - 16:00 |
Poster session |
490 - Mortality/Morbidity after Initiating ART with CD4 <100 Cells/Ul in the REALITY Trial |
Post, F |
Poster Hall D |
|
05 March 2018 |
14:30 - 16:00 |
Poster Session |
847 - Self-Harm in Adolescents with Perinatal HIV and HIV-Affected Adolescents in England |
Copelyn, J |
Poster Hall D |
|
05 March 2018 |
14:30 - 16:00 |
Poster session |
896 - Late Presentation with HIV in Africa: Phenotypes, Risk and Risk Stratification |
Gibb, D |
Poster Hall B |
|
06 March 2018 |
10:00 - 10:15 |
Oral Abstract session |
74 - Il-6, D-Dimer or T-Cells: Which Best Predict Events or Explain Benefits of Early ART? |
Baker, J |
Ballroom A |
|
06 March 2018 |
14:30 - 16:00 |
Poster session |
864 - Factors Associated with HIV DNA Levels in Children Starting ART Early in Infancy |
Chan, M |
Poster Hall D |
|
06 March 2018 |
14:30 - 16:00 |
Poster session |
531 - Effect of 12-Week Raltegravir-Intensification of First-Line ART on HIV Resistance |
Kityo, C |
Poster Hall D |
|
06 March 2018 |
14:30 - 16:00 |
Poster session |
853 - Are HIV+ Migrant Children in Europe at Increased Risk of Poor Outcomes on ART? |
Collins, IJ |
Poster Hall D |
|
06 March 2018 |
14:30 - 16:00 |
Poster session |
784 - CRAG Status and Effect on Benefits from Enhanced Prophylaxis in the REALITY Trial |
Pett, S |
Poster Hall D |
|
07 March 2018 |
10:30 - 10:45 |
Oral Abstract session |
137 - Time to Viral Rebound after Stopping ART in Children Treated from Infancy in CHER |
Chan, M |
Ballroom C |
Further information